| mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.32 |
7e-07 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
2e-06 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-05 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
3e-05 |
| mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
4e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
5e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |